Michael Dershem

Background

About Michael Dershem

Dynamic entrepreneur and venture capital acquisition executive. Outstanding track record in strategic business planning and development, capital and financial sourcing, multi-disciplinary problem solving, and technology development. Strong technology-transfer background from government and university research to private sector commercialization. Always looking to assist new venture opportunities. History over the past 15+ years includes: Served as CEO and on the Board of Directors for Pharmasset, an Emory University start-up company. Successfully raised over $20 million in private equity funding and executed a $30 million research and development agreement with DuPont. The company went public and was subsequently bought out by Gilead Sciences for $11 Billion in Fall 2011. Acquired a health care service firm and grew revenues by 50% and earnings five-fold over first year and a half, then grew into MEDassurance holding group company. Functioned as acting CEO for a Federal Laboratory start-up company QuadPharama successfully obtaining $600K in sponsored funding, a license agreement with a major research Institution, and a Phase I & II SBIR Grant for upwards to $3.3 million. Obtained over 20-technology transfer licensing agreements and CRADA’s leading to over $2 million in funding for the Department of Veterans’ Affairs. Developed the initial business start-up model for a University of Pennsylvania company that led to a successful seed round and eventual licensing portfolio company well-beyond the scope of their original intellectual property. As Chief Operations Officer for an Internet Product Company, specializing in Business-to-Consumer and Business-to-Business enterprises attracted over $500K in term sheet investment. Provided due diligence and execution for a major health care system to enter the mini-clinic/urgent care marketplace; ultimately negotiating initial placement sites with Wal-Mart and Giant Stores.